- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Updated International Consensus Guidelines for Advanced Breast Cancer Published
The guidelines have been published in 2 journals: Breast and Annals of Oncology.
The latest international consensus guidelines for the management of advanced were published online September 18 in the Annals of Oncology and September 20 in the Breast.
The advanced breast cancer 2 (ABC2) guidelines urge more research and clinical trials into treatment for advanced disease, and describe advanced breast cancer patients as a "historically neglected population."
In particular, the guidelines note, more research is needed to find the best treatments for patients with breast cancer that has spread to the liver, pleural cavity, or the skin; patients with HER2-positive advanced breast cancer who relapse during or shortly after adjuvant treatment with ; patients with stage IV disease; and men with advanced breast cancer who require treatment with aromatase inhibitors, such as , , and letrozole.
Link to the report on Medscape: http://bit.ly/1riuURB
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
